Come up with a name for your new list and we'll add to it:
Salzburg Therapeutics raised a round of funding on , . Investors include
Babcock Demon Incubator.
Salzburg Therapeutics is a drug development company that is developing Cytotoxamer and Genotoxamer products for cancer treatment. The company's technology aims to provide a solution for delivering act…